Capital increases in publicly traded biotech companies in Spain 2020, by company
In 2020, capital increases in publicly traded biotechnology companies in Spain through stock market operations reached more than 70 million euros. The biotech company with the highest capital increase was Atrys health, a multinational health care firm that provides preventive medicine, diagnosis, and treatment services, which captured around 50 million euros by issuing bonds and shares. Oryzon Genomics followed, with a capital increase of about 20 million euros as of that date.
